Replies to post #151963 on Biotech Values

[DewDiligence]

NYT editorial crows that op-ed piece by doctors at Sloan Kettering (#msg-80599468) pushed SNY to cut the price of cancer drug, Zaltrap by 50%:

http://www.nytimes.com/2012/11/13/opinion/incredible-prices-for-cancer-drugs.html